Alliance for Clinical Trials in Oncology
@alliance-org.bsky.social
Part of the National Clinical Trials Network, the Alliance for Clinical Trials in Oncology is a leader in advancing cancer research, uniting more than 25,000 cancer specialists at 115 main institutions and 1,400 affiliates across the U.S. and Canada.
Cristina Ferrone, MD, of Massachusetts General Hospital leads Alliance A021806 studying whether chemotherapy before and after surgery is better than just after surgery for pancreas cancer. Learn more: https://bit.ly/Alliance-A021806 #NCI #NCTN #pcam #PanCancer #PancSM #PancreaticCancerAwarenessMonth
November 24, 2025 at 3:40 PM
Cristina Ferrone, MD, of Massachusetts General Hospital leads Alliance A021806 studying whether chemotherapy before and after surgery is better than just after surgery for pancreas cancer. Learn more: https://bit.ly/Alliance-A021806 #NCI #NCTN #pcam #PanCancer #PancSM #PancreaticCancerAwarenessMonth
New publication! Alliance for Clinical Trials in Oncology research in the Journal of Clinical Oncology led by Matthew Wiedewult MD of Wake Forest Medical School shows targeted drugs lead to high remission rates and longer survival in tough-to-treat leukemia. https://bit.ly/Alliance-A041703-Cohort1
November 21, 2025 at 3:35 PM
New publication! Alliance for Clinical Trials in Oncology research in the Journal of Clinical Oncology led by Matthew Wiedewult MD of Wake Forest Medical School shows targeted drugs lead to high remission rates and longer survival in tough-to-treat leukemia. https://bit.ly/Alliance-A041703-Cohort1
Andrew Ko MD of UCSF Helen Diller Family Comprehensive Cancer Center and Erica Tsang MD of Princess Margaret Cancer Centre lead Alliance A022106 (PLATINUM) trial comparing two chemo regimens for pancreatic cancer. To learn more: http://bit.ly/Alliance-A022106. #PancreaticCancerAwarenessMonth
November 20, 2025 at 3:30 PM
Andrew Ko MD of UCSF Helen Diller Family Comprehensive Cancer Center and Erica Tsang MD of Princess Margaret Cancer Centre lead Alliance A022106 (PLATINUM) trial comparing two chemo regimens for pancreatic cancer. To learn more: http://bit.ly/Alliance-A022106. #PancreaticCancerAwarenessMonth
Congratulations to Linda Bulone, RN, OCN, of Queens Cancer Center at NYC Health + Hospitals for receiving the Alliance CRP RISE award from the Alliance for Clinical Trials in Oncology for her work advancing cancer research. @nychealthsystem.bsky.social https://bit.ly/CRP-RISE
November 19, 2025 at 6:52 PM
Congratulations to Linda Bulone, RN, OCN, of Queens Cancer Center at NYC Health + Hospitals for receiving the Alliance CRP RISE award from the Alliance for Clinical Trials in Oncology for her work advancing cancer research. @nychealthsystem.bsky.social https://bit.ly/CRP-RISE
Now Available: Best of Alliance at ASCO 2025 Webinar. Catch Alliance for Clinical Trials in Oncology investigators sharing key takeaways from five studies on colorectal, squamous cell, and renal cell cancers at #ASCO25. Watch at https://bit.ly/Alliance-At-ASCO American Society of Clinical Oncology
November 19, 2025 at 3:45 PM
Now Available: Best of Alliance at ASCO 2025 Webinar. Catch Alliance for Clinical Trials in Oncology investigators sharing key takeaways from five studies on colorectal, squamous cell, and renal cell cancers at #ASCO25. Watch at https://bit.ly/Alliance-At-ASCO American Society of Clinical Oncology
Reposted by Alliance for Clinical Trials in Oncology
The Alliance for Clinical Trials in Oncology appoints new committee leaders
https://cancerletter.com/in-brief/20251107_7c/
https://cancerletter.com/in-brief/20251107_7c/
The Alliance for Clinical Trials in Oncology appoints new committee leaders - The Cancer Letter
The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies. To access this subscriber-only content please log in or subscribe.If your institution has a site license, […]
cancerletter.com
November 12, 2025 at 12:00 PM
The Alliance for Clinical Trials in Oncology appoints new committee leaders
https://cancerletter.com/in-brief/20251107_7c/
https://cancerletter.com/in-brief/20251107_7c/
Trial Tuesday! Angela Bradbury MD of University of Pennsylvania leads Alliance for Clinical Trials in Oncology A232301CD seeing if chatbot intervention is as effective as remote genetic services in increasing counseling uptake among young adult cancer patients https://bit.ly/AllianceA232301CD
November 18, 2025 at 3:40 PM
Trial Tuesday! Angela Bradbury MD of University of Pennsylvania leads Alliance for Clinical Trials in Oncology A232301CD seeing if chatbot intervention is as effective as remote genetic services in increasing counseling uptake among young adult cancer patients https://bit.ly/AllianceA232301CD
Alliance for Clinical Trials in Oncology investigators recently published 51 manuscripts. Of these, 31 papers appeared in journals with an Impact Factor greater than 5; six in journals with an IF over 40. https://bit.ly/TopJournals JAMA NEJM.org Nature American Society of Clinical Oncology
November 17, 2025 at 3:40 PM
Alliance for Clinical Trials in Oncology investigators recently published 51 manuscripts. Of these, 31 papers appeared in journals with an Impact Factor greater than 5; six in journals with an IF over 40. https://bit.ly/TopJournals JAMA NEJM.org Nature American Society of Clinical Oncology
Radiation oncologist Dean Shumway, MD, of Mayo Clinic leads Alliance for Clinical Trials in Oncology A012301 (LoTam) comparing low-dose tamoxifen to usual hormonal therapy in treating post-menopausal women with early-stage HER2 #breastcancer. More at https://bit.ly/Alliance-A012301 #NCI #NCTN #BCsm
November 14, 2025 at 3:35 PM
Radiation oncologist Dean Shumway, MD, of Mayo Clinic leads Alliance for Clinical Trials in Oncology A012301 (LoTam) comparing low-dose tamoxifen to usual hormonal therapy in treating post-menopausal women with early-stage HER2 #breastcancer. More at https://bit.ly/Alliance-A012301 #NCI #NCTN #BCsm
Results from Alliance A091802 led by Dan Zanberg, MD, of @upmchillmancc.bsky.social published in The ASCO Post show a new type of immunotherapy called immune checkpoint inhibitors help people with aggressive #skincancer live longer. Read more: https://bit.ly/A091802. #NCI #NCTN
November 13, 2025 at 3:30 PM
Results from Alliance A091802 led by Dan Zanberg, MD, of @upmchillmancc.bsky.social published in The ASCO Post show a new type of immunotherapy called immune checkpoint inhibitors help people with aggressive #skincancer live longer. Read more: https://bit.ly/A091802. #NCI #NCTN
Jacob Sands MD of Dana-Farber Cancer Institute leads Alliance for Clinical Trials in Oncology A081801 (ALCHEMIST Chemo-IO) testing if adding #immunotherapy to #chemotherapy after surgery improves survival in #lungcancer. http://bit.ly/Alliance-A081801 #NSCLC #LCSM #LCAM #LungCancerAwarenessMonth
November 12, 2025 at 3:00 PM
Jacob Sands MD of Dana-Farber Cancer Institute leads Alliance for Clinical Trials in Oncology A081801 (ALCHEMIST Chemo-IO) testing if adding #immunotherapy to #chemotherapy after surgery improves survival in #lungcancer. http://bit.ly/Alliance-A081801 #NSCLC #LCSM #LCAM #LungCancerAwarenessMonth
Nice write up of Alliance's new DEFEND study on measuring how exercise impacts cancer patients in Fitt Insider.
insider.fitt.co/press-releas...
insider.fitt.co/press-releas...
New Alliance Clinical Trial Studies Impact of Exercise on Cancer Patients
DEFEND study to test if telehealth exercise plan can be successfully delivered to patients receiving chemotherapy
insider.fitt.co
November 11, 2025 at 6:28 PM
Nice write up of Alliance's new DEFEND study on measuring how exercise impacts cancer patients in Fitt Insider.
insider.fitt.co/press-releas...
insider.fitt.co/press-releas...
Jacob Sands of Dana-Farber Cancer Institute leads Alliance for Clinical Trials in Oncology A081801 (ALCHEMIST Chemo-IO) testing if adding #immunotherapy to #chemotherapy after surgery improves survival in #lungcancer. http://bit.ly/Alliance-A081801 #NSCLC #LCSM #LCAM #LungCancerAwarenessMonth
November 11, 2025 at 3:01 PM
Jacob Sands of Dana-Farber Cancer Institute leads Alliance for Clinical Trials in Oncology A081801 (ALCHEMIST Chemo-IO) testing if adding #immunotherapy to #chemotherapy after surgery improves survival in #lungcancer. http://bit.ly/Alliance-A081801 #NSCLC #LCSM #LCAM #LungCancerAwarenessMonth
New trial! Bhavana Konda, MD, MPH, of The Ohio State University leads Alliance for Clinical Trials in Oncology A092204 exploring if using two targeted drugs can help slow tumor growth in people with adrenocortical carcinoma, a adrenal gland cancer. https://bit.ly/A092204-Konda #NCI #NCTN
November 11, 2025 at 3:01 PM
New trial! Bhavana Konda, MD, MPH, of The Ohio State University leads Alliance for Clinical Trials in Oncology A092204 exploring if using two targeted drugs can help slow tumor growth in people with adrenocortical carcinoma, a adrenal gland cancer. https://bit.ly/A092204-Konda #NCI #NCTN
Alliance for Clinical Trials in Oncology has launched six new clinical trials, exploring novel therapies and innovative approaches to cancer care. From testing new drugs to evaluating digital tools, these trials aim to improve outcomes & personalize treatment. https://bit.ly/NewTrials2025 #NCI #NCTN
November 10, 2025 at 2:00 PM
Alliance for Clinical Trials in Oncology has launched six new clinical trials, exploring novel therapies and innovative approaches to cancer care. From testing new drugs to evaluating digital tools, these trials aim to improve outcomes & personalize treatment. https://bit.ly/NewTrials2025 #NCI #NCTN
It's a wrap on an exciting three-day meeting! THANK YOU to everyone participating in the 2025 Alliance Fall Group Meeting. Your remarkable efforts continue to advance cancer research. See you next spring - May 13-15! #AllianceFall25 #NCI #NCTN #NCORP #CancerResearch
November 7, 2025 at 10:00 PM
It's a wrap on an exciting three-day meeting! THANK YOU to everyone participating in the 2025 Alliance Fall Group Meeting. Your remarkable efforts continue to advance cancer research. See you next spring - May 13-15! #AllianceFall25 #NCI #NCTN #NCORP #CancerResearch
Congratulations, Linda Bulone, RN (Queens Hospital Cancer Center) - 2025 recipient of the Alliance Research Integrity Service Excellence (CRP RISE) Award! #AllianceFall25 #NCI #NCTN #NCORP #OncologyResearch
November 7, 2025 at 7:40 PM
Congratulations, Linda Bulone, RN (Queens Hospital Cancer Center) - 2025 recipient of the Alliance Research Integrity Service Excellence (CRP RISE) Award! #AllianceFall25 #NCI #NCTN #NCORP #OncologyResearch
Congratulations, Richard M. Stone, MD, of Dana-Farber Cancer Institute - recipient of the 2025 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award, presented at the 2025 Alliance Fall Group Meeting. #AllianceFall25 #NCI #NCI #NCORP #OncologyLeadership
November 7, 2025 at 5:35 PM
Congratulations, Richard M. Stone, MD, of Dana-Farber Cancer Institute - recipient of the 2025 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award, presented at the 2025 Alliance Fall Group Meeting. #AllianceFall25 #NCI #NCI #NCORP #OncologyLeadership
Happening Now! Invited speaker Saheli Sadanand, PhD, Deputy Editor, Nature Medicine, takes the stage for “Behind the Pages: Publishing with Nature Medicine.” #AllianceFall25 #NatureMedicine #OncologyResearch #ClinicalTrials
November 7, 2025 at 4:40 PM
Happening Now! Invited speaker Saheli Sadanand, PhD, Deputy Editor, Nature Medicine, takes the stage for “Behind the Pages: Publishing with Nature Medicine.” #AllianceFall25 #NatureMedicine #OncologyResearch #ClinicalTrials
Congrats to Sharon Manne, PhD, of Rutgers Cancer Institute. Dr. Manne is the 24th Annual Jimmie Holland Lecturer, presenting "Behavioral Interventions for Cancer Survivors and Their Family Members" at this year's Alliance Group Meeting. #AllianceFall25 #NCI #NCORP
November 7, 2025 at 4:30 PM
Congrats to Sharon Manne, PhD, of Rutgers Cancer Institute. Dr. Manne is the 24th Annual Jimmie Holland Lecturer, presenting "Behavioral Interventions for Cancer Survivors and Their Family Members" at this year's Alliance Group Meeting. #AllianceFall25 #NCI #NCORP
Kudos to En Cheng, MD, PhD, of the Albert Einstein School of Medicine, for one of the Most Significant Alliance Manuscripts 2024-2025! "Plant-based Diet and Survival Among - Patients with Metastatic Colorectal Cancer" in JNCI #AllianceFall25 #NCI #NCTN #CALGB-80405 #SWOG-80405
November 7, 2025 at 4:20 PM
Kudos to En Cheng, MD, PhD, of the Albert Einstein School of Medicine, for one of the Most Significant Alliance Manuscripts 2024-2025! "Plant-based Diet and Survival Among - Patients with Metastatic Colorectal Cancer" in JNCI #AllianceFall25 #NCI #NCTN #CALGB-80405 #SWOG-80405
Kudos to Jennifer Chan, MD, MPH, of Dana-Farber Cancer Institute, for one of the Most Significant Alliance Manuscripts 2024-2025! "Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors" in NEJM #AllianceFall25 #NCI #NCTN #CABINET #AllianceA021602
November 7, 2025 at 4:20 PM
Kudos to Jennifer Chan, MD, MPH, of Dana-Farber Cancer Institute, for one of the Most Significant Alliance Manuscripts 2024-2025! "Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors" in NEJM #AllianceFall25 #NCI #NCTN #CABINET #AllianceA021602
Kudos to Andrea Apolo, MD, of the National Cancer Institute, for one of the Most Significant Alliance Manuscripts 2024-2025! "Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma" in NEJM #AllianceFall25 #NCI #NCTN #AMBASSADOR #AllianceA031501
November 7, 2025 at 4:20 PM
Kudos to Andrea Apolo, MD, of the National Cancer Institute, for one of the Most Significant Alliance Manuscripts 2024-2025! "Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma" in NEJM #AllianceFall25 #NCI #NCTN #AMBASSADOR #AllianceA031501
Hats off to our newly appointed Alliance Imaging Committee leaders! Andy Plodkowski, MD, and Heiko Schöder, MD, MBA, of Memorial Sloan Kettering Cancer Center, and Jeffrey Yap, PhD, of Huntsman Cancer Institute/University of Utah! #AllianceFall25 #NCI #NCTN #Imaging
November 7, 2025 at 4:15 PM
Hats off to our newly appointed Alliance Imaging Committee leaders! Andy Plodkowski, MD, and Heiko Schöder, MD, MBA, of Memorial Sloan Kettering Cancer Center, and Jeffrey Yap, PhD, of Huntsman Cancer Institute/University of Utah! #AllianceFall25 #NCI #NCTN #Imaging
Hats off to our newly appointed Alliance Radiation Oncology Committee leaders! Co-Chairs Daniel Trifiletti, MD, of Mayo Clinic in Florida. and Joseph Salama, MD, of Duke University Medical Center. #AllianceFall25 #NCI #NCTN #RadOnc
November 7, 2025 at 4:15 PM
Hats off to our newly appointed Alliance Radiation Oncology Committee leaders! Co-Chairs Daniel Trifiletti, MD, of Mayo Clinic in Florida. and Joseph Salama, MD, of Duke University Medical Center. #AllianceFall25 #NCI #NCTN #RadOnc